HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.

AuthorsMilton Packer
JournalJACC. Heart failure (JACC Heart Fail) Vol. 7 Issue 10 Pg. 902-906 (10 2019) ISSN: 2213-1787 [Electronic] United States
PMID31521684 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Mineralocorticoid Receptor Antagonists
  • Neprilysin
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Angiotensin Receptor Antagonists (therapeutic use)
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Cardiac Resynchronization Therapy
  • Death, Sudden, Cardiac (prevention & control)
  • Defibrillators, Implantable
  • Heart Failure (physiopathology, therapy)
  • Humans
  • Mineralocorticoid Receptor Antagonists
  • Neprilysin (antagonists & inhibitors)
  • Primary Prevention
  • Tachycardia, Ventricular (physiopathology)
  • Ventricular Fibrillation (physiopathology)
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: